Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bleomycin treatment for verrucae.

Norman M Price1

  • 1Department of Dermatology, University of California School of Medicine, San Francisco, CA, USA. nmp@pricen.net

Skinmed
|July 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The treatment of actinic keratoses with a combination of 5-fluorouracil and imiquimod creams.

Journal of drugs in dermatology : JDD·2007
Same journal

Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Fenofibrate Lipid Lowering Agent.

Skinmed·2025
Same journal

Racial Disparities in the Management of Atopic Dermatitis: An Analysis of the National Ambulatory Medical Care Survey, 2012-2018.

Skinmed·2025
Same journal

"Pseudo-Chik Sign" Following COVID-19: Pigmentation Hitherto Unreported.

Skinmed·2025
Same journal

Hyperpigmented Scaly Lesions in the Axillae.

Skinmed·2025
Same journal

Sweet Syndrome-Like Disorder Induced by the Oxford-AstraZeneca<sup>®</sup> SARS-CoV-2 Vaccine.

Skinmed·2025
Same journal

Lockdown Lessons from Dermatology Consultations during the COVID-19 Pandemic in a Tertiary Care Center.

Skinmed·2025
See all related articles

Intralesional bleomycin injections effectively treat verrucae, with 96% clearance after five treatments. This method offers a convenient and rapid therapeutic option for patients and physicians, despite minor temporary side effects.

Area of Science:

  • Dermatology
  • Pharmacology

Background:

  • Bleomycin injections for verrucae treatment have been limited due to adverse effects since 1980.
  • Lack of routine adoption in dermatologic practice for verrucae treatment.

Purpose of the Study:

  • Evaluate bleomycin efficacy and adverse effects for verrucae treatment in clinical practice.
  • Demonstrate the convenience and ease of the bleomycin injection methodology.

Main Methods:

  • Retrospective study of patients with verrucae treated with intralesional bleomycin.
  • Injections administered every 3-4 weeks until lesion elimination or discontinuation due to adverse effects.

Main Results:

  • 96% of 224 verrucae lesions cleared after up to five bleomycin treatments.

Related Experiment Videos

  • High efficacy: 47.6% cleared after one treatment, 86.4% after two.
  • Minor, temporary adverse effects observed: chemical cellulitis, sterile abscesses, hyperpigmentation, pain. No severe complications.

    • Conclusions:

    • Intralesional bleomycin therapy is a rapid and convenient treatment for verrucae.
    • Offers advantages for both patients and physicians compared to alternative therapies.
    • Effective treatment with a manageable side effect profile.